Onshoring could threaten the resilient supply chain for biosimilars and generics Forcing pharmaceutical manufacturing in the U.S. threatens efficiency

https://www.statnews.com/2025/10/06/onshoring-tariffs-pharmaceuticals-biosimilars-generics-efficiency/